Welcome to our dedicated page for Liveperson SEC filings (Ticker: LPSN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The LivePerson Inc (LPSN) SEC filings page on Stock Titan centralizes the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret complex documents. LivePerson is a Nasdaq-listed software publisher in the information sector, and its filings provide detailed insight into its conversational AI platform, financial performance, capital structure, and governance.
Key filings for LPSN include annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss revenue from hosted services and professional services, trends in customer activity, non-GAAP measures such as adjusted EBITDA and free cash flow, and extensive risk factor disclosures. These reports explain how LivePerson views its position in conversational AI, outline dependencies on partners and platforms, and describe regulatory considerations around data privacy, security, and AI.
Current reports on Form 8-K are especially important for tracking material events. In 2025, LivePerson filed multiple 8-Ks describing a privately negotiated exchange of its 0% Convertible Senior Notes due 2026 for cash, new 10.0% Second Lien Senior Subordinated Secured Notes due 2029, common equity, and Series B Fixed Rate Convertible Perpetual Preferred Stock. Other 8-Ks detail the completion of a strategic refinancing that materially deleveraged the balance sheet, extended debt maturities to December 2029, and captured a significant debt discount, as well as stockholder-approved amendments to the certificate of incorporation, a 1-for-15 reverse stock split, and the conversion of Series B preferred stock into common shares.
Filings also document governance changes, such as the appointments of Ryan L. Vardeman and Nathan “Tripp” Lane to the Board of Directors, along with their compensation and any related-party considerations. Proxy materials, including the definitive proxy statement on Schedule 14A for the 2025 special meeting, provide additional detail on proposals related to authorized share increases and the reverse stock split, voting arrangements with noteholders, and ownership of securities.
On Stock Titan, these documents are updated in near real time from EDGAR and paired with AI-generated summaries that highlight what changed, why it matters, and where to find specifics on topics like debt terms, equity issuance, reverse stock split mechanics, and board appointments. Users can quickly navigate to Forms 10-K, 10-Q, 8-K, and proxy statements, and review insider-related information disclosed in Forms 3 and 4 where applicable. This makes it easier to understand how LivePerson’s regulatory record reflects its strategy, financial condition, and risk profile without reading every page manually.
LivePerson Inc. received an amended Schedule 13G from investment firm Davidson Kempner and affiliates reporting a significant ownership position. The filing states that the reporting persons beneficially own 686,800 shares of LivePerson common stock, representing 5.79% of the outstanding shares.
The percentage is calculated using 11,857,018 shares of common stock outstanding as of November 7, 2025, as disclosed in LivePerson's Form 10-Q for the quarter ended September 30, 2025. The date of the event triggering this filing is December 31, 2025.
Voting and investment decisions for the LivePerson shares held by M.H. Davidson & Co. and Davidson Kempner Arbitrage, Equities and Relative Value LP are made through Davidson Kempner Capital Management LP, with Anthony A. Yoseloff identified as responsible for these decisions. The filing certifies that the securities are not held for the purpose of changing or influencing control of LivePerson.
Linden Capital and related entities filed an amended Schedule 13G reporting a very small ownership position in LivePerson, Inc. common stock. As of December 31, 2025, Linden Advisors LP and Siu Min (Joe) Wong may each be deemed to beneficially own 5,001 shares, while Linden Capital L.P. and Linden GP LLC may each be deemed to beneficially own 4,798 shares.
Each reporting person’s holdings represent approximately 0.0% of LivePerson’s outstanding common stock, reflecting ownership of well under 5% of the class. The filing states the securities are not held for the purpose of changing or influencing control of LivePerson.
LivePerson, Inc. filed an amended report to update prior disclosures about recent additions to its Board of Directors. The company previously appointed Ryan L. Vardeman to the Board on October 14, 2025 and Nathan “Tripp” Lane on November 7, 2025.
As of January 22, 2026, the Board assigned Mr. Lane to serve on the Audit Committee and Mr. Vardeman to serve on the Compensation Committee. No other changes were made to the earlier reports, so this update is limited to clarifying committee roles for the new directors.
LivePerson Inc. insider Christopher Allen Mina, the Chief Tech Product Officer, reported an automatic sale of common stock tied to tax withholding. On January 16, 2026, 7,152 shares of LivePerson common stock were sold at $3.152 per share. According to the disclosure, these shares were sold automatically by the issuer to cover Mina’s tax liability from vesting restricted stock units, rather than as a discretionary open-market sale.
After this transaction, Mina beneficially owned 52,636 shares, which includes 43,000 unvested restricted stock units held following the transaction. The filing notes that these share amounts reflect LivePerson’s 1-for-15 reverse stock split that was effected on October 13, 2025.
A shareholder in company symbol LPSN has filed a notice of proposed sale of 7,152 shares of common stock. The shares are expected to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with an approximate sale date of 01/16/2026 and an aggregate market value of $22,539.53. The filing notes that there were 11,857,018 shares of this class outstanding. The shares to be sold were acquired on 01/15/2026 through a restricted stock vesting transaction from the issuer as compensation.
LivePerson, Inc. executive John DeNeen Collins, the company’s CFO and COO, reported an equity compensation grant. On January 5, 2026, he received an award of 34,193 restricted stock units (RSUs), each representing a contingent right to receive one share of LivePerson common stock. These RSUs are scheduled to vest on the first anniversary of the grant date, subject to his continued employment. The RSUs were granted at a price of $0 per share as a stock-based compensation award. After this grant, Collins beneficially owned 116,007 shares of common stock, including 103,764 unvested RSUs held following the reported transaction.
LivePerson, Inc. director reports pre-planned stock sale under Rule 10b5-1. Director James R. Miller sold 2,133 shares of LivePerson common stock on 12/17/2025 at a price of $4.73 per share under a Rule 10b5-1 trading plan. After this transaction, he beneficially owns 22,196 shares, which includes 13,333 unvested restricted stock units. The holding amount reflects LivePerson’s 1-for-15 reverse stock split that was effected on October 13, 2025.
LivePerson Inc.'s Chief Executive Officer and director, Anthony John Sabino, reported an automatic sale of company stock related to tax withholding. On 12/16/2025, he sold 4,984 shares of common stock at a price of $4.73 per share. The shares were sold by the issuer to cover his tax liability from the vesting of restricted stock units.
After this transaction, Sabino beneficially owned 208,765 shares of LivePerson common stock, which includes 182,581 unvested restricted stock units that remain subject to vesting conditions.
LivePerson director Ryan L. Vardeman reported an award of 23,350 restricted stock units on December 10, 2025. Each RSU represents a contingent right to receive one share of LivePerson common stock and will fully vest on December 10, 2026. The grant was made at a price of $0, reflecting stock-based compensation rather than an open-market purchase. Following this grant, Vardeman beneficially owns 23,350 shares directly through unvested RSUs and 44,422 additional shares indirectly through Palogic investment entities, as described in the ownership footnotes.
LivePerson, Inc. reported that director Nathan Lane received an equity award on December 10, 2025. He was granted 23,350 restricted stock units (RSUs) under the LivePerson, Inc. 2019 Stock Incentive Plan, each representing a contingent right to receive one share of common stock at a purchase price of $0.00 per share.
The RSUs will fully vest on December 10, 2026, as disclosed, and Lane now beneficially owns 23,350 shares in the form of unvested RSUs held directly following this grant. The transaction is reported as an acquisition of common stock related to director compensation.